A Biologic With Otologic Consequences: Analysis of Hearing Loss and Teprotumumab Using the FDA Adverse Event Reporting System
Year: 2024
Type: article
Study design: Observational Study
Source: Otology & Neurotology
Authors: Pauline P. Huynh, Elias Saba, Alexander Rivero, Robert Peralta, Jonathan Liang
Institutions: Kaiser Permanente, Kaiser Permanente Oakland Medical Center
Language: English
Subfield: Toxicology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W4401618263